Retrophin Inc. (RTRX): Scopia Capital Adds To Its Stake

Page 11 of 12

Page 11 of 12 – SEC Filing

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.

July 11, 2016

(Date)
SCOPIA CAPITAL MANAGEMENT LP

By: /s/ Samantha Nasello

Name: Samantha Nasello
Title: CCO
SCOPIA MANAGEMENT, INC.

By: /s/ Aaron Morse

Name: Aaron Morse
Title: Vice President

By: /s/ Matthew Sirovich

Name: Matthew Sirovich

By: /s/ Jeremy Mindich

Name: Jeremy Mindich

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including
all exhibits. See Rule 13d-7 for other parties for whom copies are to be sent.

Attention. Intentional misstatements or omissions of fact constitute
Federal criminal violations (see 18 U.S.C. 1001).

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)

Page 11 of 12